...
首页> 外文期刊>Indian journal of pediatrics >Comparison of Antipyretic Efficacy of Intravenous (IV) Acetaminophen versus Oral (PO) Acetaminophen in the Management of Fever in Children
【24h】

Comparison of Antipyretic Efficacy of Intravenous (IV) Acetaminophen versus Oral (PO) Acetaminophen in the Management of Fever in Children

机译:静脉注射(IV)乙酰氨基酚对乙酰乙酰乙酰苯氨基酚对儿童发烧管理中的反热效果的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objective To assess the dynamics of the onset of antipyretic efficacy of intravenous (IV) acetaminophen vs . oral (PO) acetaminophen in the management of fever in children. Methods This observational single-dose study was conducted at Department of Pedriatrics, Army Hospital (Research and Referral), a multispecialty tertiary care center in New Delhi in fever patients to assess the antipyretic efficacy of IV acetaminophen 15?mg/kg/dose vs . PO acetaminophen 15?mg/kg/dose over 6?h. Subjects were randomly assigned to receive either IV acetaminophen ( n ?=?200) or PO acetaminophen ( n ?=?200). Results Demographics and baseline characteristics were similar between the two groups and were normally distributed. Allergic reaction was found in 7 (3.5%) patients in IV acetaminophen group and was absent in PO acetaminophen group. Onset of constipation and dry mouth was found in 8 patients (4%) in IV acetaminophen group and was absent in PO acetaminophen group. Additional dose was required in 6 patients (3%) in intravenous acetaminophen group and 10 patients (5%) in oral acetaminophen group respectively. Statistically significant differences in the rate of fall in temperature through 180?min were observed in favor of the IV acetaminophen group when compared to those receiving PO acetaminophen. Conclusions A single dose of intravenous acetaminophen is safe and effective in reducing fever where patients are unable to tolerate oral administration or when rapid reduction of temperature is desirable.
机译:摘要目的评估静脉注射(IV)乙酰氨基酚VS的退热效能发作的动态。口腔(PO)乙酰氨基酚在儿童发烧管理中。方法方法,该观察单剂量研究是在养殖部,军队医院(研究和转诊)部门,在发热患者的新德里的多层高等教育中心进行,评估IV乙酰氨基酚15〜Mg / kg /剂量与vs的解热效果。 PO乙酰氨基酚15?mg / kg /剂量超过6μm。被随机分配受试者以接收静脉乙酰氨基酚(N?= 300)或PO乙酰氨基酚(N?= 300)。结果人口统计学和基线特性在两组之间类似,并且通常分布。在IV乙酰氨基酚基团的7例(3.5%)患者中发现过敏反应,在PO乙酰氨基酚基中没有。在IV乙酰氨基酚组的8名患者(4%)中发现了便秘和口干的发作,在PO乙酰氨基酚基团中没有。在口腔乙酰氨基酚组中的6名患者(3%)中需要额外的剂量(3%),分别在口服乙酰氨基酚组中10名患者(5%)。与接受PO乙酰氨基酚相比,观察到静脉内径至180℃的统计学显着差异。结论单剂量的静脉内乙酰氨基酚是安全有效的,在降低患者无法耐受口服给药或者当需要快速降低温度时,可以安全和有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号